Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2

[1]  M. Rowe,et al.  Epstein-Barr virus and Burkitt lymphoma , 2014, Chinese journal of cancer.

[2]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[3]  I. Bozzoni,et al.  Epstein–Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b , 2010, Oncogene.

[4]  M. Rowe,et al.  Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology , 2009, Seminars in cancer biology.

[5]  Hiroyuki Tagawa,et al.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.

[6]  Pin Wang,et al.  MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK21 , 2009, The Journal of Immunology.

[7]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[8]  Wei-Bin Hsu,et al.  Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. , 2009, Carcinogenesis.

[9]  E. Flemington,et al.  Epstein-Barr virus growth/latency III program alters cellular microRNA expression. , 2008, Virology.

[10]  F. Slack,et al.  Epstein-Barr virus-mediated dysregulation of human microRNA expression , 2008, Cell cycle.

[11]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[12]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[13]  C. Croce,et al.  Epstein-Barr Virus-Induced miR-155 Attenuates NF-κB Signaling and Stabilizes Latent Virus Persistence , 2008, Journal of Virology.

[14]  W. Lucchesi,et al.  Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 , 2008, Journal of Virology.

[15]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[16]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[17]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[18]  Zhen Lin,et al.  Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways , 2007, Journal of Virology.

[19]  George A Calin,et al.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. , 2007, The Journal of clinical investigation.

[20]  J. Mrázek,et al.  Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) Induces the Expression of the Cellular MicroRNA miR-146a , 2007, RNA biology.

[21]  Chris Sander,et al.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. , 2007, Blood.

[22]  D. Jong,et al.  Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma , 2007, Oncogene.

[23]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[24]  B. Kempkes,et al.  EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells , 2006, Journal of Virology.

[25]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[26]  Elliott Kieff,et al.  RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Haralambieva,et al.  Lack of BIC and microRNA miR‐155 expression in primary cases of Burkitt lymphoma , 2006, Genes, chromosomes & cancer.

[29]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[30]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[31]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.

[32]  J. Bergh,et al.  A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin Lymphoma , 2002, Leukemia & lymphoma.

[33]  S. Maruo,et al.  Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. , 2001, The Journal of general virology.

[34]  Alfonso Bellacosa,et al.  AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Kempkes,et al.  The Epstein-Barr Virus Nuclear Antigen 2 (EBNA2), a Protein Required for B Lymphocyte Immortalization, Induces the Synthesis of Type I Interferon in Burkitts Lymphoma Cell Lines , 1999 .

[37]  O. Isaksson,et al.  Expression of Epstein-Barr nuclear antigen 2 in kidney tubule cells induce tumors in transgenic mice. , 1996, Oncogene.

[38]  M. Pawlita,et al.  Epstein‐Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c‐myc gene in Burkitt's lymphoma cells. , 1996, The EMBO journal.

[39]  M. Yutsudo,et al.  Tumorigenicity of EBNA2‐transfected cells , 1995, FEBS letters.

[40]  G. Winberg,et al.  Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. , 1995, Oncogene.

[41]  E. Kremmer,et al.  B‐cell proliferation and induction of early G1‐regulating proteins by Epstein‐Barr virus mutants conditional for EBNA2. , 1995, The EMBO journal.

[42]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1 , 1995, Journal of virology.

[43]  U. Zimber-Strobl,et al.  Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes , 1994, Journal of virology.

[44]  E. Kieff,et al.  The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Longnecker,et al.  Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation , 1993, Journal of virology.

[46]  P. Åman,et al.  The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3 , 1992, Molecular and cellular biology.

[47]  S. Zimmer,et al.  Induced expression of the endogenous beta interferon gene in adenovirus type 5-transformed rat fibroblasts , 1992, Journal of virology.

[48]  J. Hiscott,et al.  trans activation of type 1 interferon promoters by simian virus 40 T antigen , 1988, Molecular and cellular biology.

[49]  G. Klein,et al.  Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[50]  L. Heston,et al.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye , 1982, Journal of virology.